TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
-14.07%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.34B
AUM Growth
+$2.34B
(-15%)
Cap. Flow
+$15.8M
Cap. Flow
% of AUM
0.67%
Top 10 Holdings %
Top 10 Hldgs %
40.93%
Holding
221
New
9
Increased
52
Reduced
52
Closed
18
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$14.9M |
| 2 |
Medtronic
MDT
|
$12.9M |
| 3 |
UnitedHealth
UNH
|
$7.69M |
| 4 |
Pfizer
PFE
|
$7.1M |
| 5 |
Merck
MRK
|
$7.1M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$17M |
| 2 |
AstraZeneca
AZN
|
$11M |
| 3 |
Idexx Laboratories
IDXX
|
$9.46M |
| 4 |
Omega Healthcare
OHI
|
$7.02M |
| 5 |
Viatris
VTRS
|
$6.94M |
Sector Composition
| 1 | Healthcare | 94.39% |
| 2 | Real Estate | 2.48% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Danaher
DHR
$147B
| $21.6M | 0.92% | 209,371 | – | – |
|
27
Zoetis
ZTS
$69.3B
| $21.5M | 0.92% | 251,415 +24,000 | +11% | +$2.05M |
|
28
Sarepta Therapeutics
SRPT
$1.78B
| $20.9M | 0.9% | 191,837 -31,345 | -14% | -$3.42M |
|
29
Humana
HUM
$36.5B
| $19.6M | 0.84% | 68,487 | – | – |
|
30
Centene
CNC
$14.3B
| $19.2M | 0.82% | 166,869 | – | – |
|
31
Intuitive Surgical
ISRG
$170B
| $18.8M | 0.8% | 39,229 +14,600 | +59% | +$6.99M |
|
32
Teva Pharmaceuticals
TEVA
$21.1B
| $18.7M | 0.8% | 1,211,868 +278,920 | +30% | +$4.3M |
|
33
BioMarin Pharmaceuticals
BMRN
$11.2B
| $17.7M | 0.76% | 207,434 +66,896 | +48% | +$5.7M |
|
|
34
AstraZeneca
AZN
$248B
| $16.3M | 0.7% | 428,024 -290,600 | -40% | -$11M |
|
35
Boston Scientific
BSX
$156B
| $15.7M | 0.67% | 444,991 | – | – |
|
36
Becton Dickinson
BDX
$55.3B
| $15.7M | 0.67% | 69,778 +5,600 | +9% | +$1.26M |
|
37
Neurocrine Biosciences
NBIX
$13.8B
| $15.4M | 0.66% | 216,294 +3,664 | +2% | +$262K |
|
38
Jazz Pharmaceuticals
JAZZ
$7.75B
| $14.3M | 0.61% | 115,187 +4,735 | +4% | +$587K |
|
39
Novo Nordisk
NVO
$251B
| $13.9M | 0.6% | 301,900 | – | – |
|
|
40
Omega Healthcare
OHI
$12.6B
| $13.4M | 0.57% | 380,122 -199,663 | -34% | -$7.02M |
|
|
SGEN
41
DELISTED
Seagen Inc. Common Stock
SGEN
| $12.8M | 0.55% | 226,239 -53,178 | -19% | -$3.01M |
|
42
Cigna
CI
$80.3B
| $12.2M | 0.52% | 64,089 +23,628 | +58% | +$4.49M |
|
|
ONC
43
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $12M | 0.51% | 85,755 | – | – |
|
44
Baxter International
BAX
$12.7B
| $10.6M | 0.45% | 161,233 +15,193 | +10% | +$1,000K |
|
45
SPDR S&P Biotech ETF
XBI
$5.07B
| $10.4M | 0.44% | 144,424 +15,424 | +12% | +$1.11M |
|
46
FibroGen
FGEN
$47.8M
| $9.85M | 0.42% | 212,763 +34,556 | +19% | +$1.6M |
|
|
BLUE
47
DELISTED
bluebird bio
BLUE
| $9.76M | 0.42% | 98,429 +10,641 | +12% | +$1.06M |
|
|
48
Idexx Laboratories
IDXX
$51.8B
| $9.59M | 0.41% | 51,575 -50,828 | -50% | -$9.46M |
|
|
SAGE
49
DELISTED
Sage Therapeutics
SAGE
| $9.43M | 0.4% | 98,444 -45,170 | -31% | -$4.33M |
|
50
Zimmer Biomet
ZBH
$21B
| $9.25M | 0.4% | 89,204 -29,642 | -25% | -$3.07M |
|